The internationally recognized One Health Microbiome Center (OHMC) in the Huck Institutes of the Life Sciences at Penn State is the recipient of a new National Institutes of Health (NIH) grant to train doctoral students in biotechnological […]
As interest in biotics1 and their wide range of health applications continues to grow, BioGaia is proud to announce the launch of a subsidiary company, BioGaia New Sciences AB, dedicated to exploring opportunities in microbiome […]
A groundbreaking UK research network has been launched to uncover how the microbiota, gut, immune system and brain are inter-connected and how they can influence mental wellbeing. Work from the research network could potentially lead […]
MaaT Pharma announces the signature of a license and commercial agreement with Clinigen, a global specialty pharmaceutical services group and a leading European player in hospital distribution and market access, to streamline the pathway for […]
Researchers have been working toward using the gut microbiome as a clinical target for screening for colorectal cancer. This would ideally allow simple stool tests to be used for early detection of the disease in […]